Incidence of Cardiovascular and Cerebrovascular Events Among Postmenopausal Women and Men With Osteoporosis Who Initiated Treatment With Denosumab or Zoledronic Acid - A Retrospective Cohort Study (20190038)

First published 20/11/2019

Last updated 13/09/2021

EU PAS number:

EUPAS32133

Study

Finalised

Documents

Study protocol

Initial protocol

20190038_01.02.06 Public Redacted Protocol Ver 1.0 2019-09-25 English

English (4.53 MB - PDF) View document

Study results

20190038_Observational Research Study Report Published Report _Redacted

English (102.93 KB - PDF) View document

Study report

Other information

Secondary tabs